Clinical trial
Effects of Dapagliflozin on the Incretin Sensitivity of the Pancreatic Beta Cell
NCT02420392 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Dapagliflozin on the Incretin Sensitivity of the Pancreatic Beta Cell
- Lead sponsor
- Seoul National University Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 28, 2015
- Completion date
- April 30, 2016
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.